Age modification of ozone associations with cardiovascular disease risk in adults: a potential role for soluble P-selectin and blood pressure.

Published

Journal Article

Background:Studies have suggested that age increases susceptibility to ozone-associated mortality, but the underlying mechanisms are unclear. In a previous study, personal exposure to ozone was significantly associated with a platelet activation biomarker, plasma soluble P-selectin (sCD62P), and blood pressure in 89 healthy adults, aged 22-52 years. The present study examines whether age modifies these associations in the same adults and in additional adults. Methods:Interaction terms of age and exposure were analyzed using hierarchical Bayesian mixed effects ridge regressions. Data from a similar additional study involving 71 healthy participants, aged 19-26 years, were pooled with the data from the first study to evaluate age effect modification when more young adults were added to the analysis. Results:In the 89 adults, significant age interactions were observed for past 24-hour and 2-week ozone exposures and sCD62P. Based on the pooled data (89 plus 71 adults), a 10 ppb increase in 24-hour ozone exposure was associated with increases in sCD62P and systolic blood pressure (SBP) by 22.3% (95% CI: 14.3%, 31.2%) and 1.35 (-0.18, 2.84) mmHg, respectively, at age 25; these values increased to 48.6% (32.7%, 65.1%) and 4.98 (2.56, 7.35) mmHg, respectively, at age 40. Conclusions:These results mechanistically suggest that increasing age enhances cardiovascular effects of ozone.

Full Text

Duke Authors

Cited Authors

  • Day, DB; Clyde, MA; Xiang, J; Li, F; Cui, X; Mo, J; Gong, J; Weschler, CJ; Zhang, Y; Zhang, JJ

Published Date

  • July 2018

Published In

Volume / Issue

  • 10 / 7

Start / End Page

  • 4643 - 4652

PubMed ID

  • 30174917

Pubmed Central ID

  • 30174917

Electronic International Standard Serial Number (EISSN)

  • 2077-6624

International Standard Serial Number (ISSN)

  • 2072-1439

Digital Object Identifier (DOI)

  • 10.21037/jtd.2018.06.135

Language

  • eng